ASML to 2035 still has a rare long-term strategic franchise, but the long-range stock outlook should be framed with explicit revenue, margin, and valuation assumptions rather than pure enthusiasm.

Eli Lilly still has a credible path to a materially larger business by 2030, but the stock is no longer cheap enough for optimism alone. The central question is whether obesity, diabetes, and pipeline ...

Mitsubishi UFJ trades at $18.84 as of May 15, 2026. Over the last 10 years the ADR ranged from $3.39 to $18.84, so the stock has already proven it can compound, but it is now much closer to the upper ...

Why Berkshire Hathaway could keep rising, with current valuation data, measurable catalysts, and scenario-based targets.

AXA through 2035: what a realistic long-range model looks like. AXA has already delivered a strong decade for shareholders: the 10-year adjusted price CAGR ...

AI can help Airbus through manufacturing efficiency, services revenue and predictive maintenance, but it is not yet a stand-alone reason for a separate stock multiple.

ASML remains one of Europe's strongest AI and semiconductor capex franchises, but the 2027 stock range still depends on order conversion, export-control risk, and valuation discipline.

Bullish drivers for Novartis based on current company data, valuation, sector context, and actionable scenarios.

Tencent stock analysis for 2030 with current valuation, AI and WeChat drivers, bull-base-bear scenarios, and investor positioning.

S&P 500 with valuation, earnings, inflation, scenario probabilities, trigger levels, and institutional data updated for mid-2026.

Walmart in context: what the current price already assumes. Walmart closed at $132.46 on May 14, 2026. Over the last 10 years, adjusted monthly closes ran ...

S&P 500 with valuation, earnings, inflation, scenario probabilities, trigger levels, and institutional data updated for mid-2026.